Disease: Hodgkin lymphoma

OPDIVO

Nivolumab 10mg/mL; per vial; soln for IV infusion after dilution; preservative-free; contains mannitol.

KEYTRUDA

Pembrolizumab 25mg/mL; per vial; soln for IV infusion after dilution; preservative-free.

ADCETRIS

Brentuximab vedotin 50mg/vial; lyophilized pwd for IV infusion after reconstitution and dilution; preservative-free.